Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

17.57 -2.19 (-11.08%)
Streaming Delayed Price Updated: 1:54 PM EDT, Jul 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 990,725
Open 18.51
Bid (Size) 17.55 (100)
Ask (Size) 17.58 (100)
Prev. Close 19.76
Today's Range 17.32 - 19.00
52wk Range 8.700 - 20.49
Shares Outstanding 84,579,542
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Integra LifeSciences (IART) Shares Are Sliding Today
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 10.1% in the afternoon session after the company reported a second-qu... 
Via StockStory
Topics Earnings
News headline image
Integra LifeSciences Q2 Earnings Call Highlights ↗
Integra LifeSciences (NASDAQ:IART) reported second-quarter 2026 revenue of $419 million, up 0.8% on a reported basis and 0.7% organically from a year earlier, as improving supply reliability and... 
Via MarketBeat
Topics Earnings World Trade

Performance

YTD
+46.3%
+46.3%
1 Month
-6.2%
-6.2%
3 Month
+63.6%
+63.6%
6 Month
+57.9%
+57.9%
1 Year
+34.1%
+34.1%

More News

Read More
Integra LifeSciences (NASDAQ:IART) Surges Over 30% on Q2 Earnings Beat ↗
Via Chartmill
News headline image
Integra LifeSciences’s (NASDAQ:IART) Q2 CY2026 Earnings Results: Revenue In Line With Expectations
Via StockStory
News headline image
Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Topics Artificial Intelligence
News headline image
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
Via StockStory
News headline image
Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm
From Kaskela Law LLC
Via Business Wire
News headline image
3 Small-Cap Stocks with Warning Signs
Via StockStory
News headline image
Why Integra LifeSciences (IART) Stock Is Up Today
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
3 Unpopular Stocks with Open Questions
Via StockStory
News headline image
1 Value Stock to Target This Week and 2 We Brush Off
Via StockStory
Topics Economy
News headline image
Surgical Equipment & Consumables - Specialty Stocks Q1 Results: Benchmarking Integra LifeSciences (NASDAQ:IART)
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
From Biotech Insider
Via GlobeNewswire
News headline image
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
From World Street Intelligence
Via GlobeNewswire
News headline image
3 Profitable Stocks We’re Skeptical Of
Via StockStory
News headline image
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
From Equity Insider
Via GlobeNewswire
News headline image
3 Reasons to Avoid IART and 1 Stock to Buy Instead
Via StockStory
Topics Bankruptcy Stocks
News headline image
Why Integra LifeSciences (IART) Stock Is Trading Up Today
Via StockStory
News headline image
3 Inflated Stocks That Concern Us
Via StockStory
News headline image
3 Stocks Under $50 with Open Questions
Via StockStory
News headline image
Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears ↗
Via MarketBeat
Topics Economy
News headline image
The Top 5 Analyst Questions From Integra LifeSciences’s Q1 Earnings Call
Via StockStory
Topics Earnings World Trade
News headline image
Why Are Integra LifeSciences (IART) Shares Soaring Today
Via StockStory
News headline image
Integra (IART) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings World Trade
News headline image
Integra LifeSciences (NASDAQ:IART) Exceeds Q1 CY2026 Expectations
Via StockStory

Frequently Asked Questions

Is Integra LifeSciences Holdings Corporation - Common Stock publicly traded?
Yes, Integra LifeSciences Holdings Corporation - Common Stock is publicly traded.
What exchange does Integra LifeSciences Holdings Corporation - Common Stock trade on?
Integra LifeSciences Holdings Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Integra LifeSciences Holdings Corporation - Common Stock?
The ticker symbol for Integra LifeSciences Holdings Corporation - Common Stock is IART on the Nasdaq Stock Market
What is the current price of Integra LifeSciences Holdings Corporation - Common Stock?
The current price of Integra LifeSciences Holdings Corporation - Common Stock is 17.57
When was Integra LifeSciences Holdings Corporation - Common Stock last traded?
The last trade of Integra LifeSciences Holdings Corporation - Common Stock was at 07/29/26 01:54 PM ET
What is the market capitalization of Integra LifeSciences Holdings Corporation - Common Stock?
The market capitalization of Integra LifeSciences Holdings Corporation - Common Stock is 1.49B
How many shares of Integra LifeSciences Holdings Corporation - Common Stock are outstanding?
Integra LifeSciences Holdings Corporation - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.